Weekly Roundup: February 22-26, 2021

February 26, 2021
Morgan Petronelli, Associate Editor

ICYMI, some of this week’s featured content includes articles on the oral, narrow-spectrum antibiotics for acne, the best practices for atopic dermatitis care, oxytocin and its effect on skin aging, plus more.

POLL: Do you listen to dermatology podcasts?

The Mainstream Patient: February 22, 2021

This week’s edition of The Mainstream Patient features stories on psoriatic arthritis medication, “slugging” to treat cystic acne, chemical peels for darker skin types, plus more.

Oral Antibiotics for the Treatment of Acne

Watch one expert detail the benefits and limitations when using oral antibiotics for the treatment of acne.

Narrow Spectrum Antibiotics for Acne

In this video interview with Dermatology Times, one expert discusses how narrow-spectrum antibiotics can both protect the skin and gut microbiome, as well as effectively treat acne.

Topical Actinic Keratosis Treatment Launched in US

Almirall announces the launch of tirbanibulin (Klisyri), a novel microtubule inhibitor for the topical treatment of actinic keratosis on the face or scalp.

Racial Differences for Preferred Acne Care

Factoring in a patient’s genetic heritage when choosing an acne care regimen could improve adherence, according to survey results that identify race-related differences in preferred sources of information and treatments for acne.

Investigators Take Global Look at Best-Practice AD Care

Several universal gaps in diagnosis and treatment of atopic dermatitis (AD) as well as real-world interventions for improvement are the focus of a ground-breaking report.

New Treatments Aim to Increase Survival Rate

Cancer staging systems for squamous cell carcinoma have helped improve dermatologists’ ability to accurately stage the cancer, according to on expert.

Clinical Study Points to Oxytocin’s Antiaging Benefits

Patients with high oxytocin levels had significantly lower (more youthful-looking) skin age scores than expected, even with strong histories of lifetime sun exposure, according to a recent study.

Novel Therapeutics Usher in a Year of Innovation

Pre- and postmarketing psoriasis studies support novel drug results and new labeling.